Sumitomo – Talk Bio

Actionable Insights Powered by AI

Biopharma Layoff Tracker 2024: Precigen, Sumitomo, BMS and More Cut Staff

9 months ago talkbio0Tagged Biopharma layoffs, Industry, Myers, pharmaceutical companies, Precigen, restructuring, squibb, Sumitomo

biopharma layoffs, Precigen, Sumitomo, Bristol Myers Squibb, biotech industry, job cuts, restructuring, pharmaceutical companies

Roivant’s Anti-Inflammatory Med Shows Promise in Phase 2 Trial for Non-Anterior Non-Infectious Uveitis

1 year ago talkbio0Tagged Brepocitinib, Humira comparison, NIU, Non-Anterior Non-Infectious Uveitis, Pharma stake acquisition, Priovant, Roivant, Stock buyback plan, Sumitomo

Roivant, Brepocitinib, Phase 2 trial success, Non-Anterior Non-Infectious Uveitis (NIU), Priovant Therapeutics, Stock buyback plan, Sumitomo Pharma stake acquisition, Humira comparison